Effective (FDA Accepted) Responses to FDA-483's and Warning Letters

In this webinar, learn how to effectively respond to warning letters that the FDA will accept. You will also learn how to negotiate with FDA to successfully close warning letters.

Purchase using Webinar All-Access Pass
One User Unlimited access to all recorded webinars for 6 Months

Recorded Version Only

(PPT + Recorded Streaming Link)

1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: Feb-2020

Download File Only

(PPT + Recorded Training File)

Downloadable file is for usage in one location only.
(For multiple locations contact Customer Care)
Downloadable link along with the materials will be emailed within 2 business days
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

The FDA-483 list of Observations following Inspections are increasing with time. FDA is also increasingly turning to warning letters as an instrument for voluntary compliance. State of the art quality systems is an FDA regulatory requirement. Simply having a procedure to follow is no longer enough. The procedure you follow may be inadequate and may, therefore, be not accepted by the FDA.

This webinar will examine the problems FDA is citing in FDA-483s and warning letters pertaining to deficiencies in the quality system. It will also examine inadequate responses and the FDA’s responses to such letters. You will learn how to prepare responses that FDA will accept. Finally, you will learn how to set up quality systems that FDA will accept.

Areas Covered in the Webinar:
  • Become familiar with issues that are on FDA-483’s and in FDA Warning Letters
  • Know what kinds of response will not be acceptable to FDA
  • Know how to effective respond to an FDA-483 or a Warning Letter
  • Know what kinds of company actions can avoid Warning Letters
  • Know how to negotiate with FDA to effectively close Warning Letters
Who Will Benefit:
  • Quality Assurance
  • Managers of Regulatory Affairs
  • Directors
  • VP’s
  • Internal GMP Auditors
  • Consultants who assist firms with Warning Letter remediation.
  • All FDA regulated companies
Instructor Profile:
Larry Stevens Larry Stevens

RAC Principal Consultant, One Way Consultants, LLC, FDA Regulatory Expert

J. Lawrence Stevens, RAC, who has over 20 years of FDA experience encompassing virtually all of the FDA field positions. Also 18 years of industry experience as a mid-level manager and senior executive in clinical, regulatory, and quality in the medical device industry. He has personally designed quality systems, prepared regulatory submissions (510(k), IDE and PMA) and managed 7 multi-center clinical trials for class 3 medical devices. From 1989-1993, was the Industry Representative on the FDA Circulatory Systems panel. Finally, a seasoned educator/speaker with over 250 public presentations to audiences ranging from senior executives, physicians, technical personnel, other medical personnel, major media, and the general public. As a consultant he has presented over 20 webinars on FDA requirements.

Mr. Stevens has met numerous times with FDA as a member of industry, and with industry numerous times as an FDA Official. He is keenly aware of what pitfalls must be avoided, and what FDA expects from the firm with whom they are meeting. Now as a consultant, Mr. Stevens assists firms in meeting FDA requirements and conducting successful FDA meetings.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed